Marie Robert

Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP Anti-ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post-TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen.

Congratulations 👏👏 to @mimrobert.bsky.social for this very nice work 🗞
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...

@arthurmageau.bsky.social Great Team 🤝🏼